Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 29 studies | 36% ± 18% | |
microglial cell | 10 studies | 30% ± 12% | |
endothelial cell | 9 studies | 31% ± 16% | |
adipocyte | 9 studies | 29% ± 8% | |
connective tissue cell | 8 studies | 32% ± 12% | |
macrophage | 8 studies | 30% ± 9% | |
pericyte | 8 studies | 26% ± 14% | |
type II pneumocyte | 7 studies | 25% ± 10% | |
astrocyte | 6 studies | 31% ± 13% | |
myofibroblast cell | 5 studies | 25% ± 7% | |
epithelial cell | 5 studies | 27% ± 10% | |
mast cell | 5 studies | 22% ± 8% | |
myeloid cell | 5 studies | 19% ± 2% | |
dendritic cell | 5 studies | 23% ± 6% | |
progenitor cell | 4 studies | 23% ± 10% | |
GABAergic neuron | 4 studies | 42% ± 16% | |
smooth muscle cell | 4 studies | 20% ± 2% | |
monocyte | 4 studies | 25% ± 5% | |
goblet cell | 4 studies | 25% ± 10% | |
hematopoietic precursor cell | 3 studies | 23% ± 9% | |
conventional dendritic cell | 3 studies | 21% ± 2% | |
glutamatergic neuron | 3 studies | 49% ± 3% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 31% ± 13% | |
alveolar macrophage | 3 studies | 23% ± 9% | |
chondrocyte | 3 studies | 43% ± 10% | |
interneuron | 3 studies | 34% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 99% | 2528.23 | 325 / 328 | 91% | 7.83 | 162 / 178 |
intestine | 100% | 3845.13 | 964 / 966 | 90% | 8.99 | 473 / 527 |
stomach | 99% | 3762.57 | 354 / 359 | 89% | 11.23 | 255 / 286 |
kidney | 99% | 2193.82 | 88 / 89 | 88% | 12.91 | 793 / 901 |
esophagus | 100% | 4832.98 | 1445 / 1445 | 87% | 7.78 | 159 / 183 |
lung | 100% | 4383.85 | 577 / 578 | 87% | 7.61 | 1004 / 1155 |
prostate | 100% | 4517.88 | 244 / 245 | 82% | 4.48 | 413 / 502 |
breast | 100% | 5256.65 | 459 / 459 | 77% | 5.48 | 856 / 1118 |
bladder | 100% | 6912.00 | 21 / 21 | 74% | 6.23 | 374 / 504 |
ovary | 100% | 5891.81 | 180 / 180 | 68% | 6.47 | 294 / 430 |
uterus | 100% | 5573.94 | 170 / 170 | 66% | 6.95 | 302 / 459 |
adrenal gland | 100% | 11193.30 | 258 / 258 | 47% | 18.94 | 108 / 230 |
thymus | 98% | 2425.23 | 641 / 653 | 44% | 1.43 | 264 / 605 |
skin | 100% | 6953.80 | 1809 / 1809 | 31% | 1.97 | 146 / 472 |
adipose | 100% | 5509.69 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6854.58 | 1331 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2413.39 | 240 / 241 | 0% | 0 | 0 / 0 |
heart | 97% | 2437.54 | 832 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 6.50 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 71% | 3.52 | 32 / 45 |
brain | 19% | 223.37 | 496 / 2642 | 38% | 1.82 | 269 / 705 |
peripheral blood | 44% | 972.60 | 405 / 929 | 0% | 0 | 0 / 0 |
muscle | 40% | 566.62 | 318 / 803 | 0% | 0 | 0 / 0 |
liver | 3% | 31.21 | 6 / 226 | 18% | 1.10 | 75 / 406 |
eye | 0% | 0 | 0 / 0 | 6% | 0.14 | 5 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | PLAGL1 |
Protein name | Pleomorphic adenoma gene-like 1 Zinc finger protein PLAGL1 (Lost on transformation 1) (LOT-1) (Pleiomorphic adenoma-like protein 1) (Tumor suppressor ZAC) PLAG1 like zinc finger 1 (Pleiomorphic adenoma gene-like protein 1) (Pleomorphic adenoma gene-like 1) PLAG1 like zinc finger 1 (Pleiomorphic adenoma gene-like protein 1) PLAG1 like zinc finger 1 |
Synonyms | ZAC LOT1 |
Description | FUNCTION: Acts as a transcriptional activator . Involved in the transcriptional regulation of type 1 receptor for pituitary adenylate cyclase-activating polypeptide. . |
Accessions | ENST00000367571.3 [Q9UM63-1] A1YLA1 A0A0D9SEQ4 ENST00000367572.3 [Q9UM63-2] ENST00000627449.2 A0A0D9SGF7 A0A2C9DUD1 ENST00000626373.2 ENST00000444202.5 [Q9UM63-1] ENST00000354765.6 [Q9UM63-1] ENST00000628651.2 ENST00000626462.2 ENST00000649307.1 [Q9UM63-1] A0A0D9SFM8 Q9UM63 ENST00000416623.5 [Q9UM63-1] ENST00000360537.6 [Q9UM63-1] ENST00000674357.1 [Q9UM63-1] ENST00000437412.5 [Q9UM63-2] A1YLA2 ENST00000629195.2 A0A0D9SFI7 ENST00000650125.1 [Q9UM63-1] ENST00000417959.4 [Q9UM63-2] ENST00000625622.2 [Q9UM63-1] ENST00000647988.1 ENST00000626294.2 ENST00000647880.1 [Q9UM63-2] A0A3B3IRN7 ENST00000649211.1 [Q9UM63-1] |